Research ArticleArticle
Generation and Characterization of a Novel Multidrug Resistance Protein 2 Humanized Mouse Line
Nico Scheer, Praveen Balimane, Michael D. Hayward, Sandra Buechel, Gunther Kauselmann and C. Roland Wolf
Drug Metabolism and Disposition November 2012, 40 (11) 2212-2218; DOI: https://doi.org/10.1124/dmd.112.047605
Nico Scheer
TaconicArtemis, Koeln, Germany (N.S., S.B., G.K.); Bristol-Myers Squibb, Princeton, New Jersey (P.B.); Taconic Biosciences, Cranbury, New Jersey (M.D.H.); CXR Biosciences Limited, Dundee, United Kingdom (C.R.W.); and Cancer Research United Kingdom Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.)
Praveen Balimane
TaconicArtemis, Koeln, Germany (N.S., S.B., G.K.); Bristol-Myers Squibb, Princeton, New Jersey (P.B.); Taconic Biosciences, Cranbury, New Jersey (M.D.H.); CXR Biosciences Limited, Dundee, United Kingdom (C.R.W.); and Cancer Research United Kingdom Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.)
Michael D. Hayward
TaconicArtemis, Koeln, Germany (N.S., S.B., G.K.); Bristol-Myers Squibb, Princeton, New Jersey (P.B.); Taconic Biosciences, Cranbury, New Jersey (M.D.H.); CXR Biosciences Limited, Dundee, United Kingdom (C.R.W.); and Cancer Research United Kingdom Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.)
Sandra Buechel
TaconicArtemis, Koeln, Germany (N.S., S.B., G.K.); Bristol-Myers Squibb, Princeton, New Jersey (P.B.); Taconic Biosciences, Cranbury, New Jersey (M.D.H.); CXR Biosciences Limited, Dundee, United Kingdom (C.R.W.); and Cancer Research United Kingdom Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.)
Gunther Kauselmann
TaconicArtemis, Koeln, Germany (N.S., S.B., G.K.); Bristol-Myers Squibb, Princeton, New Jersey (P.B.); Taconic Biosciences, Cranbury, New Jersey (M.D.H.); CXR Biosciences Limited, Dundee, United Kingdom (C.R.W.); and Cancer Research United Kingdom Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.)
C. Roland Wolf
TaconicArtemis, Koeln, Germany (N.S., S.B., G.K.); Bristol-Myers Squibb, Princeton, New Jersey (P.B.); Taconic Biosciences, Cranbury, New Jersey (M.D.H.); CXR Biosciences Limited, Dundee, United Kingdom (C.R.W.); and Cancer Research United Kingdom Molecular Pharmacology Unit, Medical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom (C.R.W.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
MRP2 HUMANIZED MICE
Nico Scheer, Praveen Balimane, Michael D. Hayward, Sandra Buechel, Gunther Kauselmann and C. Roland Wolf
Drug Metabolism and Disposition November 1, 2012, 40 (11) 2212-2218; DOI: https://doi.org/10.1124/dmd.112.047605
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement